250 related articles for article (PubMed ID: 20626584)
1. Lactobacillus reuteri in children with functional abdominal pain (FAP).
Romano C; Ferrau' V; Cavataio F; Iacono G; Spina M; Lionetti E; Comisi F; Famiani A; Comito D
J Paediatr Child Health; 2014 Oct; 50(10):E68-71. PubMed ID: 20626584
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus reuteri DSM 17938 for the Management of Functional Abdominal Pain in Childhood: A Randomized, Double-Blind, Placebo-Controlled Trial.
Weizman Z; Abu-Abed J; Binsztok M
J Pediatr; 2016 Jul; 174():160-164.e1. PubMed ID: 27156182
[TBL] [Abstract][Full Text] [Related]
3. Lactobacillus reuteri DSM 17938 and a placebo both significantly reduced symptoms in children with functional abdominal pain.
Maragkoudaki M; Chouliaras G; Orel R; Horvath A; Szajewska H; Papadopoulou A
Acta Paediatr; 2017 Nov; 106(11):1857-1862. PubMed ID: 28712129
[TBL] [Abstract][Full Text] [Related]
4. Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children: RCT Study.
Jadrešin O; Hojsak I; Mišak Z; Kekez AJ; Trbojević T; Ivković L; Kolaček S
J Pediatr Gastroenterol Nutr; 2017 Jun; 64(6):925-929. PubMed ID: 27906800
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus reuteri DSM 17938 is effective in the treatment of functional abdominal pain in children: Results of the double-blind randomized study.
Jadrešin O; Sila S; Trivić I; Mišak Z; Kolaček S; Hojsak I
Clin Nutr; 2020 Dec; 39(12):3645-3651. PubMed ID: 32362486
[TBL] [Abstract][Full Text] [Related]
6. Probiotics in Functional Gastrointestinal Disorders.
Hojsak I
Adv Exp Med Biol; 2019; 1125():121-137. PubMed ID: 30578460
[TBL] [Abstract][Full Text] [Related]
7. Use of probiotics in the treatment of functional abdominal pain in children-systematic review and meta-analysis.
Trivić I; Niseteo T; Jadrešin O; Hojsak I
Eur J Pediatr; 2021 Feb; 180(2):339-351. PubMed ID: 32940743
[TBL] [Abstract][Full Text] [Related]
8. Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double-blind, placebo-controlled trial.
Ismail NI; Nawawi KNM; Hsin DCC; Hao KW; Mahmood NRKN; Chearn GLC; Wong Z; Tamil AM; Joseph H; Raja Ali RA
Helicobacter; 2023 Dec; 28(6):e13017. PubMed ID: 37614081
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.
Kong XJ; Liu K; Zhuang P; Tian R; Liu S; Clairmont C; Lin X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Yu Z; Shen C; Cui X; Cao H; Du T; Wan G; Cao X
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1508-1520. PubMed ID: 34115318
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial.
Kubota M; Ito K; Tomimoto K; Kanazaki M; Tsukiyama K; Kubota A; Kuroki H; Fujita M; Vandenplas Y
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31952280
[TBL] [Abstract][Full Text] [Related]
11. Nutraceuticals and Pain Disorders of the Gut-Brain Interaction in Infants and Children: A Narrative Review and Practical Insights.
Salvatore S; Carlino M; Sestito S; Concolino D; Agosti M; Pensabene L
Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337634
[TBL] [Abstract][Full Text] [Related]
12. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial.
Ojetti V; Ianiro G; Tortora A; D'Angelo G; Di Rienzo TA; Bibbò S; Migneco A; Gasbarrini A
J Gastrointestin Liver Dis; 2014 Dec; 23(4):387-91. PubMed ID: 25531996
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial.
Wegner A; Banaszkiewicz A; Kierkus J; Landowski P; Korlatowicz-Bilar A; Wiecek S; Kwiecien J; Gawronska A; Dembinski L; Czaja-Bulsa G; Socha P
Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):494-500. PubMed ID: 29650440
[TBL] [Abstract][Full Text] [Related]
14. Effect of Lactobacillus reuteri LRE02-Lactobacillus rhamnosus LR04 combination and gastrointestinal functional disorders in an Emergency Department pediatric population.
Margiotta G; Ferretti S; Graglia B; Gatto A; Capossela L; Bersani G; Curatola A; Chiaretti A
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):3097-3104. PubMed ID: 33877678
[TBL] [Abstract][Full Text] [Related]
15. Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation.
Riezzo G; Orlando A; D'Attoma B; Linsalata M; Martulli M; Russo F
Benef Microbes; 2018 Jan; 9(1):51-60. PubMed ID: 29022390
[TBL] [Abstract][Full Text] [Related]
16. Probiotics promoted head growth in extremely low birthweight infants in a double-blind placebo-controlled trial.
Wejryd E; Marchini G; Frimmel V; Jonsson B; Abrahamsson T
Acta Paediatr; 2019 Jan; 108(1):62-69. PubMed ID: 29999201
[TBL] [Abstract][Full Text] [Related]
17. Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial.
Jørgensen MR; Keller MK; Kragelund C; Hamberg K; Ericson D; Nielsen CH; Twetman S
Acta Odontol Scand; 2016 Jul; 74(5):399-404. PubMed ID: 27104984
[TBL] [Abstract][Full Text] [Related]
18. Non-pharmacological management of abdominal pain-related functional gastrointestinal disorders in children.
Paul SP; Basude D
World J Pediatr; 2016 Nov; 12(4):389-398. PubMed ID: 27363985
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the effects of probiotics in pediatrics with recurrent abdominal pain.
Rahmani P; Ghouran-Orimi A; Motamed F; Moradzadeh A
Clin Exp Pediatr; 2020 Dec; 63(12):485-490. PubMed ID: 32718147
[TBL] [Abstract][Full Text] [Related]
20. Increasing work-place healthiness with the probiotic Lactobacillus reuteri: a randomised, double-blind placebo-controlled study.
Tubelius P; Stan V; Zachrisson A
Environ Health; 2005 Nov; 4():25. PubMed ID: 16274475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
